The FDA announced a voluntary recall of 16 lots of Clonazepam Orally Disintegrating Tablets due to mislabeling errors. The incorrect dosage information poses serious health risks, including life-threatening side effects. Endo Inc. has reported no adverse incidents related to the recall as of November 21, 2024.